An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Clinical trial NCT01521065 · UNKNOWN
Trial details
- NCT number
- NCT01521065
- Sponsor
- Oraya Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-10-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.